Cargando…
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis: An Observational Study
Rheumatoid arthritis (RA) is characterized by increased insulin resistance, a well-known risk factor for diabetes and cardiovascular diseases. The aim of the present study was to evaluate the effect of abatacept on insulin sensitivity in RA patients with moderate to severe disease despite treatment...
Autores principales: | Ursini, Francesco, Russo, Emilio, Letizia Hribal, Marta, Mauro, Daniele, Savarino, Francesca, Bruno, Caterina, Tripolino, Cesare, Rubino, Mariangela, Naty, Saverio, Grembiale, Rosa Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616417/ https://www.ncbi.nlm.nih.gov/pubmed/26020396 http://dx.doi.org/10.1097/MD.0000000000000888 |
Ejemplares similares
-
Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study
por: Ursini, Francesco, et al.
Publicado: (2016) -
Abatacept in psoriatic arthritis: Case report and short review
por: Ursini, Francesco, et al.
Publicado: (2013) -
Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy
por: Ursini, Francesco, et al.
Publicado: (2015) -
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study
por: Ruscitti, Piero, et al.
Publicado: (2017) -
Effect of abatacept treatment on serum osteoclast-related biomarkers in patients with rheumatoid arthritis (RA): A multicenter RA ultrasound prospective cohort in Japan
por: Kawashiri, Shin-Ya, et al.
Publicado: (2021)